Stockreport

Sesen Bio Announces Successful Type C Meeting with FDA for Vicinium

Sesen Bio, Inc.  (SESN) 
Last sesen bio, inc. earnings: 11/12 07:00 am Check Earnings Report
PDF Alignment reached with FDA on post-marketing confirmatory trial design CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio (Nasdaq: SESN), a late-stage clinical company deve [Read more]